Rxo Inc (NYSE:RXO - Get Free Report) has been assigned an average rating of "Hold" from the twenty ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, fifteen have assigned a hold rating, three have given a buy rating and one has given a strong buy rating to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $27.32.
A number of brokerages have weighed in on RXO. The Goldman Sachs Group upped their price objective on shares of RXO from $18.00 to $20.00 and gave the stock a "neutral" rating in a research report on Thursday, July 16th. Weiss Ratings restated a "sell (d-)" rating on shares of RXO in a research report on Tuesday, September 1st. UBS Group upped their target price on RXO from $23.00 to $30.25 and gave the stock a "neutral" rating in a research note on Wednesday, November 4th. William Blair set a $30.00 price objective on shares of RXO in a report on Friday, August 7th. Finally, Stifel Nicolaus set a $31.00 target price on shares of RXO in a research report on Friday, August 7th.
Read Our Latest Report on RXO
RXO Price Performance
NYSE RXO opened at $27.92 on Wednesday. The company has a market cap of $4.61 billion, a price-to-earnings ratio of -54.75 and a beta of 1.96. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.28 and a quick ratio of 1.28. The stock's fifty day moving average price is $24.61 and its 200 day moving average price is $21.46. RXO has a 1 year low of $10.43 and a 1 year high of $29.90.
RXO (NYSE:RXO - Get Free Report) last released its earnings results on Thursday, October 29th. The company reported $0.09 EPS for the quarter, topping analysts' consensus estimates of $0.08 by $0.01. The firm had revenue of $1.87 billion during the quarter, compared to the consensus estimate of $1.82 billion. RXO had a negative return on equity of 0.07% and a negative net margin of 1.35%. The company's revenue was up 31.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.01 earnings per share. As a group, equities research analysts forecast that RXO will post 0.16 earnings per share for the current year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Intrinsic Edge Capital Management LLC purchased a new stake in shares of RXO during the first quarter worth approximately $3,655,000. Sei Investments Co. raised its stake in RXO by 71.7% in the 1st quarter. Sei Investments Co. now owns 133,339 shares of the company's stock valued at $1,949,000 after purchasing an additional 55,680 shares during the last quarter. Fifth Third Bancorp lifted its holdings in RXO by 21,691.7% in the 1st quarter. Fifth Third Bancorp now owns 146,222 shares of the company's stock valued at $2,138,000 after purchasing an additional 145,551 shares in the last quarter. Bank of America Corp DE lifted its holdings in RXO by 128.6% in the 1st quarter. Bank of America Corp DE now owns 724,060 shares of the company's stock valued at $10,586,000 after purchasing an additional 407,285 shares in the last quarter. Finally, Maple Rock Capital Partners Inc. acquired a new stake in RXO in the 2nd quarter valued at about $71,283,000. 92.73% of the stock is owned by hedge funds and other institutional investors.
About RXO
(
Get Free Report)
RXO, Inc. is an asset-light transportation and logistics provider that connects shippers with carriers through a technology-enabled freight brokerage platform. Its services include truckload and less-than-truckload brokerage, managed transportation, freight forwarding and last-mile delivery. The company serves customers primarily across North America, coordinating transportation for a range of industries and shipment types. Its technology helps customers manage shipping activity and provides visibility into freight movements.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider RXO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.
While RXO currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.